Kousi, Maria
Söylemez, Onuralp
Ozanturk, Aysegül
Mourtzi, Niki
Akle, Sebastian
Jungreis, Irwin http://orcid.org/0000-0002-3197-5367
Muller, Jean http://orcid.org/0000-0002-7682-559X
Cassa, Christopher A.
Brand, Harrison
Mokry, Jill Anne http://orcid.org/0000-0001-5664-7987
Wolf, Maxim Y.
Sadeghpour, Azita
McFadden, Kelsey
Lewis, Richard A.
Talkowski, Michael E. http://orcid.org/0000-0003-2889-0992
Dollfus, Hélène
Kellis, Manolis http://orcid.org/0000-0001-7113-9630
Davis, Erica E. http://orcid.org/0000-0002-2412-8397
Sunyaev, Shamil R. http://orcid.org/0000-0001-5715-5677
Katsanis, Nicholas http://orcid.org/0000-0002-2480-0171
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (HD042601)
Article History
Received: 30 March 2018
Accepted: 31 August 2020
First Online: 12 October 2020
Competing interests
: N.K. is a founder of, and holds significant stock in, Rescindo Therapeutics.